+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Testicular sex cord stromal tumors: analysis of patients from the MAKEI study

Testicular sex cord stromal tumors: analysis of patients from the MAKEI study

Pediatric Blood and Cancer 60(10): 1651-1655

In children and adolescents, testicular sex cord stromal tumors (TSCSTs) are rare. There is only limited information available regarding their clinical presentation, biology, and prognosis. Between 1993 and 2009, 42 patients were prospectively reported to the cooperative MAHO and MAKEI studies on childhood germ cell tumors. Based on standardized documentation, data on epidemiology, clinical presentation, diagnostic features, histopathological differentiation, therapy, and follow-up were evaluated. During the study period, a gradual increase of the documentation of these rare tumors was observed. Palpable, indolent testicular swelling was the most common clinical finding. In three patients, retention of the testis was observed. Two patients showed sexual precocity, and one patient showed a 45X/46XY mosaic. Juvenile granulosa cell tumors (n = 16) and Sertoli cell tumor (n = 15) were the leading histopathological subtypes. The first were commonly diagnosed during the first weeks of life (median age: 6(0-162) days, the latter during infancy (median 7(0-14) months, P < 0.05). Other histological diagnoses included Leydig cell and Large Cell Calcifying Sertoli cell tumors (both n = 3) and not-otherwise-specified TSCSTs (n = 5), which were diagnosed during childhood and adolescence. All tumors were limited to the testis; there were no metastases. Treatment was surgical, only. After a median follow-up of 3.8 years, no relapse was observed. Diagnosis and therapy of testicular tumors should be planned in accordance with the recommendations of the respective childhood germ cell tumor protocols. High inguinal orchiectomy is safe and constitutes definitive therapy. Diagnostic work-up and follow-up should also consider potentially associated tumor predisposition syndromes.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 056150349

Download citation: RISBibTeXText

PMID: 23733594

DOI: 10.1002/pbc.24607

Related references

Non-testicular germ cell tumors: analysis of the therapy study MAKEI 83/86 anc changes in the protocol for the follow-up study. Klinische Padiatrie 201(4): 247-260, 1989

Testicular sex cord stromal tumors in pediatric patients clinicopathologic study of 11 cases. Laboratory Investigation 64(1): 109A, 1991

Chemotherapy associated toxicity in patients with malignant non testicular germ cell tumours Comparison of MAKEI 83/86 and MAKEI 89. Jones, W G , Harnden, P , Appleyard, I Advances in the Biosciences; Germ cell tumours III : 67-68, 1994

Perspectives on testicular sex cord-stromal tumors and those composed of both germ cells and sex cord-stromal derivatives with a comparison to corresponding ovarian neoplasms. Human Pathology 65: 1-14, 2017

Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study. Klinische Padiatrie 203(4): 236-245, 1991

Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors?. Cancer 98(4): 753-757, 2003

Immunohistochemical study of testicular sex cord-stromal tumors, including staining with anti-inhibin antibody. American Journal of Surgical Pathology 22(5): 615-619, 1998

Mutational analysis (c.402C>G) of the FOXL2 gene and immunohistochemical expression of the FOXL2 protein in testicular adult type granulosa cell tumors and incompletely differentiated sex cord stromal tumors. Applied Immunohistochemistry and Molecular Morphology 19(4): 347-351, 2011

Treatment strategy in non-testicular malignant germ cell tumors in children and adolescents--concept of the MAKEI 83 cooperative therapeutic study of the Society for Pediatric Oncology. Klinische Padiatrie 195(3): 201-206, 1983

Testicular sex cord-stromal tumors in children: clinicopathologic study of sixteen children with review of the literature. Pediatric Pathology & Laboratory Medicine 16(3): 451-470, 1996

Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: a prospective evaluation of 71 patients treated in the German cooperative protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89. Journal of Clinical Oncology 21(5): 781-786, 2003

Intracranial germ cell tumors: analysis of the therapy study MAKEI 83/86 and changes in protocol for the follow-up study. Klinische Padiatrie 201(4): 261-268, 1989

Does RPLND have a curative role for sex cord-stromal testicular tumors?. Journal of Urology 167(4 Supplement): 155, April, 2002

Müllerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors. Human Pathology. 29(8): 840-845,., 1998

Recent advances in the diagnosis and classification of testicular sex cord-stromal tumors. Zhonghua Bing Li Xue Za Zhi 47(2): 139-142, 2018